Caplight Logo









Pando Bioscience

Pando Bioscience

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://www.pando.bio/

Last Round

Seed

Feb 9, 2023

Total Funding Raised

$500,000

Momentum Score

25 /100

Company Overview

Pando Bioscience is an AI-driven synthetic biology company that focuses on enzyme engineering for the pharmaceutical, manufacturing, and diagnostics industries. The company utilizes a proprietary ultra-high-throughput screening platform, which it claims can screen enzymes significantly faster and more cheaply than traditional methods. This platform empowers its generative AI models to optimize enzymes across multiple properties, aiming to deliver high-performing, industrial-grade enzymes. By integrating AI design with advanced screening, Pando helps pharmaceutical companies improve existing enzymes and discover new ones, with the goal of reducing costs and increasing productivity in the production of active pharmaceutical ingredients (APIs). The company was part of the Y Combinator Winter 2023 batch.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

enzyme engineeringAI enzyme designsynthetic biologysynbiogenerative AIhigh-throughput screeningprotein engineeringbiotech AIpharmaceutical manufacturingdrug discoveryactive pharmaceutical ingredientAPI manufacturingdiagnosticsbiocatalysiscontract research organizationCROproprietary enzymes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pando Bioscience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pando Bioscience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 9, 2023

Key People

Founding team and executive leadership

Yang Wang

Co-founder And CTO

Founding Team

Will Cao

Co-founder, CEO

Founding Team

Pando Bioscience Investors

Notable investors and investment history

Pando Bioscience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pando Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pando Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range6
Year Founded2022
Last FundingFeb 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.